Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
INVACARE CORP (IVC)
Sector: Healthcare; Industry: Medical Devices

Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators; and Invacare HomeFill oxygen systems. Further, it sells and distributes healthcare furnishings consisting of long-term care beds, case goods, safe patient handling equipment, and other equipment and accessories for long-term care customers. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-07-15 LaPlaca Anthony Sr. VP and General Counsel Sell 1,400 $7.77 $10,878 No
2021-01-27 LaPlaca Anthony Sr. VP and General Counsel Sell 100 $10.95 $1,095 No
2021-01-20 LaPlaca Anthony Sr. VP and General Counsel Sell 1,500 $10.45 $15,675 No
2021-01-15 LaPlaca Anthony Sr. VP and General Counsel Sell 7,500 $9.93 $74,475 No
2018-11-20 Leneghan Kathleen P. Senior VP and CFO Buy 6,500 $5.52 $35,900 No
2018-11-19 NASTAS CLIFFORD D Director Buy 9,000 $5.42 $48,814 No
2018-11-08 Monaghan Matthew E. Chairman, President and CEO Buy 13,750 $7.26 $99,847 No
2018-06-29 Childers Dean J. SVP & GM, North America Sell 7,000 $18.71 $130,977 No
2018-06-15 Shah Baiju R. Director Sell 4,000 $19.65 $78,600 No
2018-06-14 LaPlaca Anthony Sr. VP and General Counsel Sell 20,000 $19.59 $391,820 Yes
2018-05-23 HARRIS C MARTIN Director Sell 2,582 $16.38 $42,280 No
2018-02-15 HARRIS C MARTIN Director Sell 3,443 $18.15 $62,501 No
2017-09-13 Childers Dean J. SVP & GM, North America Sell 6,249 $15.15 $94,697 No
2017-05-16 LaPorte Dale C Director Sell 2,737 $14.95 $40,918 No
2016-11-16 LaPorte Dale C Director Sell 375 $11.90 $4,462 No
2016-11-02 Shah Baiju R. Director Buy 1,000 $9.04 $9,036 No
2016-11-02 Monaghan Matthew E. Chairman, President and CEO Buy 11,000 $9.00 $99,000 No
2016-08-04 HARRIS C MARTIN Director Sell 475 $11.49 $5,458 No
2016-05-17 LaPorte Dale C Director Sell 375 $10.33 $3,874 No
2016-05-16 Childers Dean J. SVP & GM, North America Buy 10,000 $10.40 $104,040 No
2016-05-06 NASTAS CLIFFORD D Director Buy 5,000 $11.01 $55,050 No
2016-05-03 Monaghan Matthew E. Chairman, President and CEO Buy 4,500 $11.39 $51,255 No
2016-05-02 LaPlaca Anthony Sr. VP and General Counsel Buy 1,000 $11.23 $11,230 No
2016-05-02 Shah Baiju R. Director Buy 2,000 $11.27 $22,540 No
2016-02-29 Monaghan Matthew E. Chairman, President and CEO Buy 8,000 $12.31 $98,517 No
2016-02-29 LaPlaca Anthony Sr. VP and General Counsel Buy 1,000 $12.38 $12,380 No
2016-02-29 Gudbranson Robert K Senior VP and CFO Buy 4,200 $12.01 $50,442 No
2015-12-10 DELANEY MICHAEL F Director Sell 1,000 $19.05 $19,052 No
2015-06-09 DELANEY MICHAEL F Director Sell 1,250 $22.79 $28,488 No
2014-12-08 HARRIS C MARTIN Director Sell 1,125 $16.22 $18,251 No

Insider Smart

PENN NATIONAL GAMING INC (PENN) - PENN took a deep dive from $36 to $5 due to the crash, anyone who was bold enough to pick up some shares in March or April could have made a 900% profit in 2 months. But bottom fishing is always easier said than done, if one took a safer bet and followed multiple insider buying around $18, a 100% profit is still impressive.

Insider Smart

Edesa Biotech, Inc. (EDSA) - President and CEO bought shares of EDSA in late May around $3, two weeks after their purchase, the stock jump to $9, very well timed buy.